Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Sensyne Health Begins Trading on AIM
Posted
August 17, 2018
Views
1,131
Likes
4
Engagement
0.35%
August 17, 2018
1,131
4
0.35%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:54Now PlayingAug.17 -- Paul Drayson, chief executive officer at Sensyne Health, discusses how his company uses artificial intelligence to analyze clinical data of patients, how it helps the pharmaceutical discovery process, how they could utilize blockchain, what excites investors about the technology, why this is the right time for them to IPO, and his concerns over Brexit. He speaks on "Bloomberg Daybreak: Europe."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
